3ntg
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | {{Seed}} | ||
[[Image:3ntg.png|left|200px]] | [[Image:3ntg.png|left|200px]] | ||
Line 20: | Line 19: | ||
==About this Structure== | ==About this Structure== | ||
- | + | [[3ntg]] is a 4 chain structure with sequence from [http://en.wikipedia.org/wiki/Mus_musculus Mus musculus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=3NTG OCA]. | |
==Reference== | ==Reference== | ||
<ref group="xtra">PMID:20709553</ref><references group="xtra"/> | <ref group="xtra">PMID:20709553</ref><references group="xtra"/> | ||
[[Category: Mus musculus]] | [[Category: Mus musculus]] | ||
+ | [[Category: Prostaglandin-endoperoxide synthase]] | ||
[[Category: Carter, J C.]] | [[Category: Carter, J C.]] | ||
[[Category: Graneto, M J.]] | [[Category: Graneto, M J.]] | ||
Line 31: | Line 31: | ||
[[Category: Talley, J J.]] | [[Category: Talley, J J.]] | ||
[[Category: Wang, J L.]] | [[Category: Wang, J L.]] | ||
- | [[Category: Cox-2]] | ||
- | [[Category: Cox2]] | ||
- | [[Category: Cyclooxygenase-2]] | ||
- | [[Category: Dioxygenase]] | ||
- | [[Category: Disulfide bond]] | ||
- | [[Category: Endoplasmic reticulum]] | ||
- | [[Category: Fatty acid biosynthesis]] | ||
- | [[Category: Glycoprotein]] | ||
- | [[Category: Heme]] | ||
- | [[Category: Iron]] | ||
- | [[Category: Lipid synthesis]] | ||
- | [[Category: Membrane]] | ||
- | [[Category: Metal-binding]] | ||
- | [[Category: Microsome]] | ||
- | [[Category: Oxidoreductase]] | ||
- | [[Category: Peroxidase]] | ||
- | [[Category: Pgh2s-2]] | ||
- | [[Category: Phosphoprotein]] | ||
- | [[Category: Prostaglandin biosynthesis]] | ||
- | |||
- | ''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Wed Dec 1 11:02:47 2010'' |
Revision as of 06:19, 23 March 2011
Crystal structure of COX-2 with selective compound 23d-(R)
Template:ABSTRACT PUBMED 20709553
About this Structure
3ntg is a 4 chain structure with sequence from Mus musculus. Full crystallographic information is available from OCA.
Reference
- Wang JL, Limburg D, Graneto MJ, Springer J, Hamper JR, Liao S, Pawlitz JL, Kurumbail RG, Maziasz T, Talley JJ, Kiefer JR, Carter J. The novel benzopyran class of selective cyclooxygenase-2 inhibitors. Part 2: The second clinical candidate having a shorter and favorable human half-life. Bioorg Med Chem Lett. 2010 Jul 24. PMID:20709553 doi:10.1016/j.bmcl.2010.07.054